1,25-dihydroxyvitamin D3 attenuates type 1 diabetes-related myocardial apoptosis and fibrosis by influencing the interaction of FoxO1 and p-Smad3
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.115128 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Tiantian Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Hospital of China Medical University, Shenyang, Liaoning 110001, People's Republic of China. Hauptthemen laut MEDLINE: Smad3 Protein, Forkhead Box Protein O1, Diabetes Mellitus, Type 1, Diabetic Cardiomyopathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Major Research Plan, National Natural Science Foundation of China, Liaoning Provincial Natural Science Foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetic cardiomyopathy (DCM) is one of the most important complications of diabetes. Vitamin D deficiency further increases the risk of heart failure (HF) and death in patients with diabetes. This study aimed at investigating the role of 1,25D3 in alleviating type 1 diabetes-related myocardial apoptosis and fibrosis by influencing the interaction of FoxO1 and p-Smad3. First, we found that vitamin D deficiency augments the risk of HF associated with elevated HbA1c in community-dwelling older adults. 1,25D3 partially ameliorated cardiac function and histological structural changes and reduced the expression levels of myocardial apoptosis and fibrosis proteins in streptozotocin-induced type 1 diabetes mouse model. In H9c2 cells, 1,25D3 treatment inhibited the expression of apoptosis and fibrosis marker proteins induced by high glucose (HG) in a dose-dependent manner. In addition, 1,25D3 treatment inhibited HG-stimulated FoxO1 and Smad3 signalling in vivo and in vitro. However, the cardioprotective effects of 1,25D3 were eliminated by FoxO1 overexpression. The co-immunoprecipitation experiments demonstrated that the interaction between p-Smad3 and FoxO1 proteins and 1,25D3 or FoxO1 inhibitor AS1842856 (AS) treatment could effectively suppress this association and the mRNA level of fibrotic gene Col-1. Our data suggest that 1,25D3 attenuates myocardial apoptosis and fibrosis in DCM by inhibiting the interaction between FoxO1 and p-Smad3. This study proposes a new mechanism and strongly supports the idea that 1,25D3 may be effective as a therapeutic agent for DCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, The First Hospital of China Medical University, Shenyang, Liaoning 110001, People's Republic of China.
- Department of Gerontology and Geriatrics, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China.
- Department of Gerontology and Geriatrics, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China. Electronic address: dfwang@cmu.edu.cn.
Förderung
- Major Research Plan
- National Natural Science Foundation of China
- Liaoning Provincial Natural Science Foundation
- Key Research and Development Program of Liaoning Province
Zitieren
APA
Zhang, T., Hu, J., Li, Z., Tian, T., Huang, R., Li, N., & Wang, D. (2025). 1,25-dihydroxyvitamin D3 attenuates type 1 diabetes-related myocardial apoptosis and fibrosis by influencing the interaction of FoxO1 and p-Smad3. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115128
Vancouver
Zhang T, Hu J, Li Z, Tian T, Huang R, Li N, et al. 1,25-dihydroxyvitamin D3 attenuates type 1 diabetes-related myocardial apoptosis and fibrosis by influencing the interaction of FoxO1 and p-Smad3. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115128
BibTeX
@article{Zhang2025,
author = {Zhang, Tiantian and Hu, Junwei and Li, Zhichi and Tian, Tingting and Huang, Runnian and Li, Na and Wang, Difei},
title = {1,25-dihydroxyvitamin D3 attenuates type 1 diabetes-related myocardial apoptosis and fibrosis by influencing the interaction of FoxO1 and p-Smad3},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.115128}
}
EUVIMED